CCND1 and nonpapillary renal cell carcinoma: To further clarify whether the miR-625–CCND1 axis is responsible for the impact of LINC00511 on ccRCC progression, rescue experiments were carried out by introducing the miR-625 inhibitor into LINC00511-deficient A498 and 786-O cells.